Premium
中国产后抑郁症网络干预(“Mommy go”):随机对照试验方案
Author(s) -
Li YuHong,
Mu TingYu,
Zhang Liu,
Zhang ChengLu,
Wu Dan,
Chen JinJu,
Wang Fang
Publication year - 2020
Publication title -
journal of advanced nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 155
eISSN - 1365-2648
pISSN - 0309-2402
DOI - 10.1111/jan.14436
Subject(s) - postpartum depression , edinburgh postnatal depression scale , randomized controlled trial , psychological intervention , mood , medicine , depression (economics) , postpartum period , clinical trial , intervention (counseling) , psychiatry , clinical psychology , pregnancy , anxiety , depressive symptoms , genetics , surgery , macroeconomics , pathology , economics , biology
Abstract Aim The purpose of this study is to design a research protocol for the clinical testing of the “Mommy go” for pregnant women with a risk of postpartum depression. Design A non‐blinded randomized controlled trial. Methods A randomized controlled study will be performed from January 2018 to the completion of the study. The intervention group will follow the “Mommy go” protocol and the control group will receive traditional support. We will use the Edinburgh Postpartum Depression Scale and the Chinese version of the Postpartum Depression Predictors Inventory‐Revised to measure the risk of postpartum depression in pregnant women. The outcomes are clinical data, postpartum depressive mood, self‐efficacy, and infant temperament. Outcomes will be assessed using questionnaires and through data generated by digital technologies. Discussion The expected outcomes are increased self‐efficacy and infant temperament, reduced postpartum depressive mood, and improvements to postpartum depression. We expect the study to have a clinical impact on future online interventions for postpartum depression in China. Impact This study will provide an internet‐based intervention for postpartum depression in China. It will be implemented in clinical practice if it can effectively improve postpartum depression. Trial Registration Registered at the Chinese Clinical Trials.gov (ChiCTR1800018804).